Treatment of chronic idiopathic urticaria with combined H1 and H2 blockers

Clin Allergy. 1978 Sep;8(5):429-33. doi: 10.1111/j.1365-2222.1978.tb01493.x.

Abstract

Combined H1 (cyproheptadine) and H2 antihistamines (cimetidine) were tried in eight patients with chronic urticaria who were previously unresponsive to conventional anti-urticarial regimens, including type I antihistamines, hydroxyzine, ephedrine and corticosteroids. 50% of the patients responded with 90% or greater improvement within 10 days. The remaining 50% showed no benefit. Side effects of the medications were minimal. These results indicate that a 10 day trial of both H1 and H2 antihistamines may be useful in patients with chronic urticaria resistant to all other standard treatment modalities.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Chronic Disease
  • Cimetidine / therapeutic use
  • Cyproheptadine / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Histamine H1 Antagonists / therapeutic use*
  • Histamine H2 Antagonists / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Urticaria / drug therapy*

Substances

  • Histamine H1 Antagonists
  • Histamine H2 Antagonists
  • Cyproheptadine
  • Cimetidine